Skip to main navigation Skip to search Skip to main content

Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia

  • Yongsheng Ruan
  • , Hye Na Kim
  • , Heather A. Ogana
  • , Zesheng Wan
  • , Samantha Hurwitz
  • , Cydney Nichols
  • , Nour Abdel-Azim
  • , Ariana Coba
  • , Seyoung Seo
  • , Yong Hwee Eddie Loh
  • , Eun Ji Gang
  • , Hisham Abdel-Azim
  • , Chih Lin Hsieh
  • , Michael R. Lieber
  • , Chintan Parekh
  • , Dhananjay Pal
  • , Deepa Bhojwani
  • , Donald L. Durden
  • , Yong Mi Kim

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number766888
JournalFrontiers in Oncology
Volume11
DOIs
StatePublished - Dec 1 2021
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • BRD4
  • PI3Kδ
  • SF2535
  • acute lymphoblastic leukemia
  • c-Myc
  • p-AKT

Cite this